Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
June 10th, 2026
Delaware, Pennsylvania Advance Bills on Surveillance Pricing
Andrew Folks was recently quoted in the Privacy Daily’s article “Delaware, Pennsylvania Advance Bills on Surveillance Pricing.” Recently The Delaware House Economic Development Committee approved a proposed ban on using personal data and algorithms to set different prices for different consumers and Pennsylvania cleared a surveillance-pricing bill focused on rideshare companies. Businesses are increasingly having access to consumer data and automated decision-making systems that can determine what a particular consumer might be willing or able to pay, but Folks warns that business “using algorithms and personal data to set prices are grappling with an increasingly fragmented set of risks”.
Read the full article on the new surveillance pricing bills. (Behind paywall)
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
